Echinococcus IgM ELISA Kit

The Echinococcus IgM ELISA Kit is a semi-quantitative enzyme-linked immunosorbent assay (ELISA) designed to detect IgM antibodies to Echinococcus species in human serum or plasma. This kit is specifically designed for early detection of acute echinococcosis infections and is intended for use by trained medical professionals.

Echinococcosis, also known as hydatid disease, is caused by cestodes of the genus Echinococcus. Humans serve as intermediate hosts and become infected through ingestion of eggs from contaminated animal feces. Cysts may develop in various organs, primarily the liver and lungs, resulting in cystic hydatid disease (CHD) or alveolar hydatid disease (AHD). The antibody response varies based on cyst location and calcification, with liver cysts typically producing stronger responses than lung cysts.

This assay uses microplates coated with Echinococcus excretory antigens to detect specific IgM antibodies. The reaction is visualized through a clear color change, providing results that can be read visually or with an ELISA reader. The kit offers a reliable and efficient method for clinical diagnosis and epidemiological studies.

Echinococcus IgM ELISA Kit

√  Early Detection: IgM antibody detection identifies acute infections.

√  High Sensitivity: Detects low levels of IgM antibodies for accurate diagnosis.

√  High Specificity: Minimizes cross-reactivity through optimized antigens.

√  Rapid Testing: Short testing time allows for efficient screening.

√  Clear Results: Strong colorimetric reaction enables easy result interpretation.

√  Stable Storage: Reagents are stable at 2-8°C for long-term reliability.

√  Quality Assurance: Includes positive and negative controls for consistent results.

√  Standardized Workflow: Streamlined protocol ensures ease of use in clinical laboratories.

Echinococcus IgM ELISA Kit

√  Clinical Laboratories: Early screening and diagnosis of echinococcosis.

√  Public Health Centers: Epidemiological studies and high-risk group screenings.

√  Parasitology Research Institutions: Studies on the immunology and pathology of echinococcosis.

√  Remote Healthcare Facilities: Reliable diagnostic tools for resource-limited settings.

√  Public Health Programs: Health interventions in endemic regions.

√  International Quarantine Services: Screening of travelers from high-risk areas.

√  Agricultural and Veterinary Sectors: Monitoring and risk assessment of echinococcosis transmission.